Prostate brachytherapy seed migration and dosimetry: Analysis of stranded sources and other potential predictive factors

Brachytherapy

Volumn 3, Issue 1, 2004, Pages 10-19

  Fuller, Donald B ^a   Koziol, James A ^b   Feng, Anne C ^b  

^a Radiation Medical Group Inc   (United States)

^b SCRIPPS CLINIC   (United States)

Author keywords

Dosimetry; Prostate brachytherapy; Seed migration; Stranded

Indexed keywords

ARTICLE; BRACHYTHERAPY; CONTROLLED STUDY; DOSIMETRY; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; MIGRATION; NEEDLE; ORGAN SIZE; PREDICTION; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; RADIATION DOSE; URETHRA;

BRACHYTHERAPY; COHORT STUDIES; HUMANS; IODINE RADIOISOTOPES; MALE; PALLADIUM; PROSTATIC NEOPLASMS; RADIOISOTOPES; RADIOMETRY; TREATMENT OUTCOME;

EID: 1942424928     PISSN: 15384721     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brachy.2004.02.003     Document Type: Article

References (18)

1. Ankem M.K., DeCarvahlo V.S., Harangozo A.M., et al. Implications of radioactive seed migration to the lungs after prostate brachytherapy. Urology. 59:2002;555-559.
2. Davis B.J., Pfeifer E.A., Wilson T.M., et al. Prostate brachytherapy seed migration to the right ventricle found at autopsy following acute cardiac dysrhythmia. J Urol. 164:2000;1661.
3. Merrick G.S., Butler W.M., Tollenaar B.G., et al. The dosimetry of prostate brachytherapy-induced urethral strictures. Int J Radiat Oncol Biol Phys. 52:2002;461-468.
4. Merrick G.S., Butler W.M., Wallner K.E., et al. The importance of radiation doses to the penile bulb vs. crura in the development of post-brachytherapy erectile dysfunction. Int J Radiat Oncol Biol Phys. 54:2002;1055-1062.
5. Potters L., Cao Y., Calugaru E., et al. A comprehensive review of CT-based dosimetry parameters and biochemical control in patients treated with permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys. 50:2001;605-614.
6. 125I prostate implants. Int J Radiat Oncol Biol Phys. 41:1998;101-108.
7. Merrick G.S., Butler W.M., Dorsey A.T., et al. Seed fixity in the prostate/periprostatic region following brachytherapy. Int J Radiat Oncol Biol Phys. 46:2000;215-220.
8. Nag S., Vivekanandam S., Martinez-Monge R. Pulmonary embolization of permanently implanted radioactive palladium-103 seeds for carcinoma of the prostate. Int J Radiat Oncol Biol Phys. 39:1997;667-670.
9. Older R.A., Snyder B., Krupski T.L., et al. Radioactive implant migration in patients treated for localized prostate cancer with interstitial brachytherapy. J Urol. 165:2001;1590-1592.
10. Tapen E.M., Blasko J.C., Grimm P.D., et al. Reduction of radioactive seed embolization to the lung following prostate brachytherapy. Int J Radiat Oncol Biol Phys. 42:1998;1063-1067.
11. Nath R., Roberts K., Ng M., et al. Correlation of medical dosimetry quality indicators in the local tumor control in patients with prostate cancer treated with iodine-125 interstitial implants. Med Phys. 25:1998;2293-2307.
12. Stock R.G., Stone N.N. Importance of post-implant dosimetry in permanent prostate brachytherapy. Eur Urol. 41:2002;434-439.
13. 103Pd for low-risk prostate cancer: Preliminary PSA outcomes from a prospective randomized multicenter trial. Int J Radiat Oncol Biol Phys. 57:2003;1297-1303.
14. Zelefsky M.J., Yamada Y., Cohen G., et al. Dosimetric predictors of prolonged grade 2 urinary symptoms after prostate implantation: What does the urethral DVH teach us? Brachytherapy. 2:2003;63. (abstract P-64).
15. 103Pd. Int J Radiat Oncol Biol Phys. 32:1995;373-378.
16. Lee W.R., deGuzman A.F., Tomlinson S.K., et al. Radioactive sources embedded in suture are associated with improved postimplant dosimetry in men treated with prostate brachytherapy. Radiother Oncol. 65:2002;123-127.
17. Merrick G.S., Butler W.M., Dorsey A.T., et al. Effect of prostate size and isotope selection on dosimetric quality following permanent seed implantation. Tech Urol. 7:2001;233-240.
18. 125I prostate implants: Definitions and factors affecting outcome. Int J Radiat Oncol Biol Phys. 48:2000;899-906.